VivoSim Labs, INC. (VIVS) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US68620A3023
VivoSim Labs, INC. financials
| Fiscal year | 2025 | 2026 |
|---|---|---|
| Revenue | 144,000.00 USD | 131,000.00 USD |
| Gross profit | 139,000.00 USD | 131,000.00 USD |
| Operating income | -12.62 m USD | -11.49 m USD |
| EBIT | -2.62 m USD | -14.10 m USD |
| Net income | -2.49 m USD | -13.84 m USD |
| Diluted EPS – continuing operations | -1.70 USD | -5.35 USD |
Full history since 2009, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About VivoSim Labs, INC.
VivoSim Labs, Inc., a pharmaceutical and biotechnology services company, provides testing of drugs and drug candidates in three-dimensional (3D) human tissue models of liver and intestine. It offers partners liver and intestinal toxicology insights through its new approach methodologies (NAM) models. The company also provides liver toxicology predictive screening and research services, as well as works on predicting and studying the intestinal side effect profiles of drugs that are therapeutic candidates of pharmaceutical and biotech companies at various stages of drug development; and build functional 3D human tissues through its proprietary technologies that mimic key aspects of native human tissue composition, architecture, function, and disease. In addition, it offers 3D human tissue platform that develops novel human normal and disease models using high throughput systems, bioprinted, and flow/stretch capable 3D systems. The company was formerly known as Organovo Holdings, Inc. and changed its name to VivoSim Labs, Inc. in April 2025. VivoSim Labs, Inc. was incorporated in 2007 and is headquartered in San Diego, California.
More stocks
- reAlpha Tech Corp. (AIRE)
- Yellowstone Group Ltd. (YSGL)
- Bluejay Diagnostics, Inc. (BJDX)
- Power REIT (PW)
- SenesTech, Inc. (SNES)
- HealthLynked Corp (HLYK)
- OFA Group (OFAL)
- KALA BIO, Inc. (KALA)
- Quantum Genesis AI Corp. (QGAI)
- My City Builders, Inc. (MYCB)
- Dror Ortho-Design, Inc. (DROR)
- GBT Technologies Inc. (GTCH)
Not investment advice. All data without warranty, price as of 12.11.2026. Details in the risk notice.